Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Gainers
- Legacy Reserves Inc (NASDAQ:LGCY) shares rose 96.4% to $0.10 in pre-market trading, reversing from recent weakness. Shares fell earlier this week after the company filed for Chapter 11 bankruptcy protection.
- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV) rose 61.5% to $6.93 in pre-market trading after the FDA responded to the company’s IND package and concurred with the company’s proposed plan for further preclinical studies to support the development of CRV431 in NASH.
- Lifeway Foods, Inc. . (NASDAQ:LWAY) shares rose 9.1% to $3.98 in pre-market trading. Lifeway Foods shares jumped over 26% Thursday after the company announced it will enter the CBD space with CBD drinkables once it is legalized at federal level by FDA.
- Arbutus Biopharma Corporation (NASDAQ:ABUS) rose 8.5% to $2.56 in pre-market trading after surging 37.21% on Thursday.
- Achieve Life Sciences, Inc. (NASDAQ:ACHV) rose 5.4% to $2.54 in pre-market trading after the company disclosed that Phase 2b ORCA-1 trial data has been accepted for oral presentation at Society for Research on Nicotine & Tobacco Europe (SRNT-E) Annual Conference.
- Mustang Bio, Inc. (NASDAQ:MBIO) rose 5.3% to $3.55 in pre-market trading after falling 6.91% on Thursday.
- IAMGOLD Corporation (NYSE:IAG) rose 4.6% to $3.39 in pre-market trading after climbing 7.64% on Thursday.
- The Meet Group, Inc.. (NASDAQ:MEET) rose 4.6% to $3.65 in pre-market trading. Oppenheimer initiated coverage on The Meet Group with an Outperform rating.
- Verastem Inc (NASDAQ:VSTM) rose 4.4% to $1.66 in pre-market trading after the company presented COPIKTRA data showing response rates of 44-57%, including complete response rates of 15-22% in patients with relapsed or refractory peripheral T-cell lymphoma.
- Rapid7, Inc. (NASDAQ:RPD) rose 4.4% to $59.84 in pre-market trading after gaining 5.06% on Thursday.
- CarMax, Inc (NYSE:KMX) rose 3.9% to $86.23 in pre-market trading after the company reported better-than-expected Q1 EPS and sales.
- Nabors Industries Ltd. (NYSE:NBR) rose 3% to $2.77 in pre-market trading after gaining 8.91% on Thursday.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Check out these big penny stock gainers and losers
Losers
- AnaptysBio, Inc. (NASDAQ:ANAB) fell 15.1% to $56.90 in pre-market trading after Credit Suisse downgraded the stock from Outperform to Neutral.
- Hertz Global Holdings, Inc. (NYSE:HTZ) shares fell 11.6% to $16.50 in pre-market trading.
- Akerna Corp. (NASDAQ:KERN) fell 7% to $34.00 in pre-market trading after dropping 26.61% on Thursday.
- Melinta Therapeutics, Inc. (NASDAQ:MLNT) fell 6.6% to $4.93 in pre-market trading after dropping 17.63% on Thursday.
- Brookfield Business Partners L.P. (NYSE:BBU) shares fell 6.2% to $38.67 in pre-market trading after reporting a $795 million equity offering.
- 500.com Limited (NYSE:WBAI) fell 5.6% to $9.33 in pre-market trading after rising 6.93% on Thursday.
- Beyond Meat, Inc. (NASDAQ:BYND) fell 5.6% to $156.00 in pre-market trading.
- Exelixis, Inc. (NASDAQ:EXEL) fell 5.4% to $20.00 in pre-market trading.
- Canopy Growth Corp (NYSE:CGC) fell 4.8% to $41.60 in pre-market trading after the company posted its financial results for the fiscal fourth quarter ended March 31, which included annual net revenue growth of 191%.
- Carnival Corporation (NYSE:CCL) fell 4.5% to $46.61 in pre-market trading after Barclays downgraded the company's stock from Overweight to Equal-Weight and lowered the price target from $69 to $55. Nomura also downgraded the stock from Buy to Neutral and lowered the price target from $60 to $52. The company on Thursday cut FY19 guidance.
- BioTelemetry, Inc. (NASDAQ:BEAT) fell 4.2% to $49.00 in pre-market trading.
- MoneyGram International, Inc. (NASDAQ:MGI) fell 4.1% to $2.56 in pre-market trading after declining 8.87% on Thursday.
- Edesa Biotech, Inc. (NASDAQ:EDSA) fell 4% to $7.11 in pre-market trading after jumping 74.94% on Thursday.
- Alexandria Real Estate Equities Inc (NYSE:ARE) fell 2.3% to $146.50 in pre-market trading. Alexandria Real Estate Equities priced upsized public offering of 3.85 million shares of common stock at $145 per share.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.